A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.
about
Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: a literature reviewAssociation between NQO1 C609T polymorphism and prostate cancer riskHybridization-Induced Aggregation Technology for Practical Clinical Testing: KRAS Mutation Detection in Lung and Colorectal Tumors.Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemiaSensiScreen®KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.KRAS mutation analysis by PCR: a comparison of two methods.Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective techniqueEstablishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform.Assessment of high resolution melt analysis feasibility for evaluation of beta-globin gene mutations as a reproducible, cost-efficient and fast alternative to the present conventional methodRNA-Seq analysis identifies a novel set of editing substrates for human ADAR2 present in Saccharomyces cerevisiae.Low-frequency KRAS mutations are prevalent in lung adenocarcinomasRechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer.Isocitrate dehydrogenase 1 and 2 mutations in gliomas.Pragmatic issues in biomarker evaluation for targeted therapies in cancer.Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses.Study on Inhibitory Effect of MaiMenDong Decoction and WeiJing Decoction Combination with Cisplatin on NCI-A549 Xenograft in Nude Mice and Its Mechanism.Whole genome amplification induced bias in the detection of KRAS-mutated cell populations during colorectal carcinoma tissue testing.Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAF mutations.Association between IL-4 -589C>T polymorphism and colorectal cancer risk.NPM1 Mutation Analysis in Acute Myeloid Leukemia: Comparison of Three Techniques - Sanger Sequencing, Pyrosequencing, and Real-Time Polymerase Chain Reaction.Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.QIAGEN Therascreen KRAS RGQ Assay, QIAGEN KRAS Pyro Assay, and Dideoxy Sequencing for Clinical Laboratory Analysis of KRAS Mutations in Tumor Specimens.
P2860
Q26785713-7F6801E8-9D17-44A2-B5A6-BFD0625C59FAQ28240340-2875EE4A-B889-47E7-BDE7-161BDB267D38Q30276632-A362814F-8959-4D2C-89D2-2A60E6F8D434Q33712307-4DDB9AED-18D6-404F-8CEF-48D4DD12F268Q33821751-DA12DB4E-229F-4C52-976D-06D5698C7FF2Q34748747-C141F896-13EC-4DF9-A85E-CC6E8E677976Q34876437-7E590FFF-8384-4DC6-A343-D1E743978A6CQ35721438-6643D721-25EB-44D6-B687-F6F324126FFEQ36849673-4F8C7121-0FD2-47C3-9A2A-E7A3A4D6D539Q36861354-C6CEB67D-7246-4A7C-856B-1A44DBC38DAEQ37375826-F2517D5C-3B02-4347-8D73-2E3DA7E8B705Q37375834-D0CB738D-CF5A-456E-832B-95F7D4374A83Q38163598-FC497861-EE1F-465F-A608-B7E9A736A551Q38235572-BE6E11FF-17E9-41F4-B959-809BF4015505Q38271031-CD8074A3-3439-40EB-A3D0-6D7F1E7372F8Q39284284-B2C68C5C-8174-49FD-BC20-C6E895FF4FE1Q41243431-AA7ABEF0-1E81-4461-9E09-1DE8357EE9C0Q41473889-50583CF7-6182-41F6-B12C-D92C34EAEEDFQ41874659-AF18009C-0B37-477A-B9F5-E9398E93BB6EQ46735674-5959B861-6E61-4807-84D2-B80C0A12A6D9Q50054236-C60327FF-25BF-4FAA-B328-5FDB303B4655Q53134069-2F48EA14-0842-41C1-A15B-369C976A503DQ53220042-116CD123-7881-423B-8BAF-7792219E56F2
P2860
A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@ast
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@en
type
label
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@ast
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@en
prefLabel
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@ast
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@en
P2093
P2860
P356
P1476
A comparison of Direct sequenc ...... on small cell lung carcinomas.
@en
P2093
Danuta Radzioch
Ivona Grygarkova
Jiri Drabek
Jiri Klein
Jitka Berkovcova
Josef Skarda
Marcela Stankova
Marian Hajduch
Sylwia Jancik
Tomas Tichy
P2860
P2888
P356
10.1186/1756-9966-31-79
P577
2012-09-20T00:00:00Z
P5875
P6179
1008892946